跳至主要内容
临床试验/CTRI/2010/091/001036
CTRI/2010/091/001036已完成4 期

A randomized double blind Trial comparing Efficacy and Safety of Duloxetine vs. Amitriptyline in painful Diabetic Neuropathy

PGIMER0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
PGIMER
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Inclusion criteria
  • 1. Presence of type 2 diabetes mellitus
  • 2. No change in anti-diabetic medication for the last 1 month
  • 3. Evidence of diabetic neuropathy by Diabetic Neuropathy
  • Symptom Score >1 point, Diabetic Neuropathy Examination Score
  • >4 point, Vibration perception test and monofilament test.
  • 4. Neuropathic pain present for at least 1 month
  • 5. Mean pain intensity of more than 50% by patient assessment by

排除标准

  • Exclusion criteria
  • 1. Age below 18 or above 75 years
  • 2. Evidence of renal disease (Se. creatinine > 1.5)
  • 3. Evidence of liver disease (deranged LFT with clinical evidence)
  • 4. Pregnant and lactating mothers and women intending pregnancy
  • 5. Evidence of other causes for neuropathy and painful conditions
  • 6. Epilepsy, psychiatric and cardiac diseases, hypertensives not on
  • peripheral vascular disease and substance abuse.
  • 7. Intake of anticonvulsants, antidepressants, membrane
  • stabilizers and opioids
  • 8. Participation in any other clinical trial with in the last 30 days

研究者

发起方
PGIMER

相似试验